GLENMARK - Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited Share Market Related News
-: Stock News :- GLENMARK 16-06-2022 To 16-06-2022
-: Stock News :- GLENMARK 16-06-2022 To 16-06-2022

✔️ Glenmark Pharma launches asthma drug Indamet

View Full Story
-: Stock News :- GLENMARK 13-06-2022 To 13-06-2022
-: Stock News :- GLENMARK 13-06-2022 To 13-06-2022

✔️ Glenmark Pharma shares hit 52-week low on reports of USFDA inspection at Baddi plant

View Full Story
-: Stock News :- GLENMARK 28-05-2022 To 28-05-2022
-: Stock News :- GLENMARK 28-05-2022 To 28-05-2022

✔️ Glenmark Pharmaceuticals Q4 Results: Net dips 26% to Rs 173 cr
✔️ Glenmark Pharmaceuticals Q4 consolidated PAT declines 26% to Rs 173 cr

View Full Story
-: Stock News :- GLENMARK 20-05-2022 To 28-05-2022
-: Stock News :- GLENMARK 20-05-2022 To 28-05-2022

✔️ Glenmark Pharma gets final USFDA nod for generic version of Abiraterone Acetate tablets
✔️ Glenmark Pharmaceuticals Q4 consolidated PAT declines 26% to Rs 173 cr

View Full Story
-: Stock News :- GLENMARK 09-05-2022 To 09-05-2022
-: Stock News :- GLENMARK 09-05-2022 To 09-05-2022

✔️ Glenmark gets tentative nod from USFDA for generic psoriasis foam
✔️ Glenmark gets tentative nod from USFDA for generic psoriasis foam

View Full Story
-: Stock News :- GLENMARK 14-04-2022 To 09-05-2022
-: Stock News :- GLENMARK 14-04-2022 To 09-05-2022

✔️ Glenmark Pharmaceuticals Q4 PAT may dip 20.1% YoY to Rs 186.8 cr: Prabhudas Lilladher
✔️ Glenmark gets tentative nod from USFDA for generic psoriasis foam

View Full Story
-: Stock News :- GLENMARK 11-04-2022 To 11-04-2022
-: Stock News :- GLENMARK 11-04-2022 To 11-04-2022

✔️ Glenmark to conduct clinical trials of its molecule on cancer patients
✔️ Glenmark Pharma shares gain on DCGI nod to clinical trial of 'novel' small molecule

View Full Story
-: Stock News :- GLENMARK 21-03-2022 To 21-03-2022
-: Stock News :- GLENMARK 21-03-2022 To 21-03-2022

✔️ Glenmark Pharma receives US FDA approval for lacosamide tablets to treat seizure
✔️ Glenmark Pharmaceuticals' subsidiary gets US greenlight for Lacosamide tablets
✔️ Glenmark Pharmaceuticals gets final USFDA nod for Lacosamide tablet
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 09-02-2022 To 21-03-2022
-: Stock News :- GLENMARK 09-02-2022 To 21-03-2022

✔️ Glenmark Pharma share price rises 2% on launch of nasal spray for COVID-19 patients
✔️ Glenmark Pharmaceuticals' subsidiary gets US greenlight for Lacosamide tablets
✔️ Glenmark Pharmaceuticals gets final USFDA nod for Lacosamide tablet
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 28-01-2022 To 21-03-2022
-: Stock News :- GLENMARK 28-01-2022 To 21-03-2022

✔️ Glenmark gets nod from US Food & Drug Administration for generic drug
✔️ Glenmark Pharma gets USFDA nod for generic drug
✔️ Glenmark Pharmaceuticals gets final USFDA nod for Lacosamide tablet
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 27-01-2022 To 21-03-2022
-: Stock News :- GLENMARK 27-01-2022 To 21-03-2022

✔️ Glenmark Pharma arm gets final USFDA approval for blood pressure drug
✔️ Glenmark Pharma gets USFDA nod for generic drug
✔️ Glenmark Pharmaceuticals gets final USFDA nod for Lacosamide tablet
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 20-01-2022 To 21-03-2022
-: Stock News :- GLENMARK 20-01-2022 To 21-03-2022

✔️ Glenmark Pharma inks exclusive licensing agreement with Lotus International
✔️ Glenmark Pharma inks exclusive licensing agreement with Lotus International
✔️ Glenmark Pharmaceuticals gets final USFDA nod for Lacosamide tablet
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 17-01-2022 To 21-03-2022
-: Stock News :- GLENMARK 17-01-2022 To 21-03-2022

✔️ Glenmark Pharma gets tentative FDA nod for generic Regadenoson injection
✔️ Glenmark Pharma gets tentative USFDA nod for generic Regadenoson injection
✔️ Glenmark Pharmaceuticals gets final USFDA nod for Lacosamide tablet
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 14-01-2022 To 21-03-2022
-: Stock News :- GLENMARK 14-01-2022 To 21-03-2022

✔️ Glenmark gets FDA approval for nasal spray for seasonal allergic rhinitis
✔️ Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitis
✔️ Glenmark Pharma gets USFDA nod for nasal spray to treat seasonal allergic rhinitis
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 13-01-2022 To 21-03-2022
-: Stock News :- GLENMARK 13-01-2022 To 21-03-2022

✔️ Glenmark Pharmaceuticals Q3 PAT seen up 17.8% YoY to Rs 292.4 cr: Prabhudas Lilladher
✔️ Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitis
✔️ Glenmark Pharma gets USFDA nod for nasal spray to treat seasonal allergic rhinitis
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 18-11-2021 To 21-03-2022
-: Stock News :- GLENMARK 18-11-2021 To 21-03-2022

✔️ Accumulate Glenmark Pharmaceuticals target of Rs 575: Geojit
✔️ Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitis
✔️ Glenmark Pharma gets USFDA nod for nasal spray to treat seasonal allergic rhinitis
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 16-11-2021 To 21-03-2022
-: Stock News :- GLENMARK 16-11-2021 To 21-03-2022

✔️ Neutral Glenmark Pharma; target of Rs 560: Motilal Oswal
✔️ Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 13-11-2021 To 21-03-2022
-: Stock News :- GLENMARK 13-11-2021 To 21-03-2022

✔️ Glenmark Pharma PAT grows 10.1%, revenue grows 6.6% in Sept quarter
✔️ Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 11-10-2021 To 21-03-2022
-: Stock News :- GLENMARK 11-10-2021 To 21-03-2022

✔️ Glenmark Pharma launches Tavulus for COPD treatment in Spain
✔️ Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 06-10-2021 To 21-03-2022
-: Stock News :- GLENMARK 06-10-2021 To 21-03-2022

✔️ Glenmark Pharmaceuticals Q2 PAT seen up 18.4% YoY to Rs 269.5 cr: Prabhudas Lilladher
✔️ Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 26-09-2021 To 21-03-2022
-: Stock News :- GLENMARK 26-09-2021 To 21-03-2022

✔️ Glenmark Pharmaceuticals sees potential of NONS to prevent Covid-19
✔️ Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 21-09-2021 To 21-03-2022
-: Stock News :- GLENMARK 21-09-2021 To 21-03-2022

✔️ Glenmark Pharma gets USFDA nod for generic antibiotic cream
✔️ Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 15-09-2021 To 21-03-2022
-: Stock News :- GLENMARK 15-09-2021 To 21-03-2022

✔️ Covid-19 drug Favipiravir safe, effective, says Glenmark
✔️ Accumulate Glenmark Pharmaceuticals; target of Rs 600: Prabhudas Lilladher
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 19-08-2021 To 21-03-2022
-: Stock News :- GLENMARK 19-08-2021 To 21-03-2022

✔️ Neutral Glenmark Pharma; target of Rs 600: Motilal Oswal
✔️ Buy Glenmark Pharmaceuticals; target of Rs 680: ICICI Direct
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 14-08-2021 To 21-03-2022
-: Stock News :- GLENMARK 14-08-2021 To 21-03-2022

✔️ Glenmark Pharma reports revenue growth of 26% and PAT growth of 21% YoY
✔️ Glenmark Pharma Q1 consolidated net profit up 21% at Rs 306 crore
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 02-08-2021 To 21-03-2022
-: Stock News :- GLENMARK 02-08-2021 To 21-03-2022

✔️ Glenmark Pharma teams up with Canadian firm produce anti-COVID nasal spray
✔️ Glenmark Pharma Q1 consolidated net profit up 21% at Rs 306 crore
✔️ Glenmark Pharma share price falls 3%; Morgan Stanley remains 'underweight'
✔️ Glenmark Pharma rises 2% as Lacosamide tablets get final approval from US watchdog

View Full Story
-: Stock News :- GLENMARK 26-07-2021 To 25-07-2021
-: Stock News :- GLENMARK 26-07-2021 To 25-07-2021

✔️ Glenmark Life raises Rs454 cr via 19 anchor investors
✔️ Glenmark Life Sciences IPO To Open Tomorrow. Key Things To Know
✔️ Subscribe to Glenmark Life Sciences: Anand Rathi
✔️ Street signs: Glenmark Life GMP at 25%, HNIs in-the-money in Tatva & more

View Full Story
-: Stock News :- GLENMARK 22-07-2021 To 25-07-2021
-: Stock News :- GLENMARK 22-07-2021 To 25-07-2021

✔️ Glenmark Life Sciences to invest Rs 600 cr to double capacity in four years
✔️ Glenmark Life Sciences IPO To Open Tomorrow. Key Things To Know
✔️ Subscribe to Glenmark Life Sciences: Anand Rathi
✔️ Street signs: Glenmark Life GMP at 25%, HNIs in-the-money in Tatva & more

View Full Story
-: Stock News :- GLENMARK 21-07-2021 To 20-07-2021
-: Stock News :- GLENMARK 21-07-2021 To 20-07-2021

✔️ Glenmark Lifesciences to double manufacturing capacity in five years
✔️ Glenmark Life Science IPO price band set at 695-720 per share
✔️ Glenmark Life Sciences IPO To Open on July 27. Here's All You Need To Know
✔️ Glenmark Pharma's API arm Glenmark Life Sciences to launch IPO on July 27, raise around Rs 1,515 crore; listing likely on August 6
✔️ Glenmark Life IPO to open next week. Issue size, date, other details here
✔️ Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

View Full Story
-: Stock News :- GLENMARK 13-07-2021 To 20-07-2021
-: Stock News :- GLENMARK 13-07-2021 To 20-07-2021

✔️ Glenmark Pharma Q1 PAT seen up 23.3% YoY to Rs 313.1 cr: KRChoksey
✔️ Glenmark Life Science IPO price band set at 695-720 per share
✔️ Glenmark Life Sciences IPO To Open on July 27. Here's All You Need To Know
✔️ Glenmark Pharma's API arm Glenmark Life Sciences to launch IPO on July 27, raise around Rs 1,515 crore; listing likely on August 6
✔️ Glenmark Life IPO to open next week. Issue size, date, other details here
✔️ Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

View Full Story
-: Stock News :- GLENMARK 25-06-2021 To 20-07-2021
-: Stock News :- GLENMARK 25-06-2021 To 20-07-2021

✔️ Glenmark Pharma gets USFDA approval for generic lung cancer drug
✔️ Glenmark Life Science IPO price band set at 695-720 per share
✔️ Glenmark Life Sciences IPO To Open on July 27. Here's All You Need To Know
✔️ Glenmark Pharma's API arm Glenmark Life Sciences to launch IPO on July 27, raise around Rs 1,515 crore; listing likely on August 6
✔️ Glenmark Life IPO to open next week. Issue size, date, other details here
✔️ Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

View Full Story
-: Stock News :- GLENMARK 23-06-2021 To 20-07-2021
-: Stock News :- GLENMARK 23-06-2021 To 20-07-2021

✔️ Glenmark Pharma gets USFDA nod for inhalation product
✔️ Glenmark Pharma gets US health regulator nod for inhalation product
✔️ Glenmark Life Sciences IPO To Open on July 27. Here's All You Need To Know
✔️ Glenmark Pharma's API arm Glenmark Life Sciences to launch IPO on July 27, raise around Rs 1,515 crore; listing likely on August 6
✔️ Glenmark Life IPO to open next week. Issue size, date, other details here
✔️ Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

View Full Story
-: Stock News :- GLENMARK 09-06-2021 To 20-07-2021
-: Stock News :- GLENMARK 09-06-2021 To 20-07-2021

✔️ Glenmark Pharma releases interim data from PMS study on Favipiravir
✔️ Glenmark says post-marketing study of COVID-19 antiviral Fabiflu supports the drug safety and effectiveness
✔️ Glenmark Life Sciences, Utkarsh SFB get Sebi nod to float IPOs
✔️ Glenmark Pharma's API arm Glenmark Life Sciences to launch IPO on July 27, raise around Rs 1,515 crore; listing likely on August 6
✔️ Glenmark Life IPO to open next week. Issue size, date, other details here
✔️ Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

View Full Story
-: Stock News :- GLENMARK 04-06-2021 To 20-07-2021
-: Stock News :- GLENMARK 04-06-2021 To 20-07-2021

✔️ Glenmark Pharma gets final nod from USFDA for Theophylline ER tablets
✔️ Glenmark says post-marketing study of COVID-19 antiviral Fabiflu supports the drug safety and effectiveness
✔️ Glenmark Life Sciences, Utkarsh SFB get Sebi nod to float IPOs
✔️ Glenmark Pharma's API arm Glenmark Life Sciences to launch IPO on July 27, raise around Rs 1,515 crore; listing likely on August 6
✔️ Glenmark Life IPO to open next week. Issue size, date, other details here
✔️ Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

View Full Story
-: Stock News :- GLENMARK 01-06-2021 To 31-05-2021
-: Stock News :- GLENMARK 01-06-2021 To 31-05-2021

✔️ Glenmark needs to work harder on reducing its debt
✔️ Reduce Glenmark Pharmaceuticals target of Rs 509: Prabhudas Lilladher
✔️ Glenmark Standalone March 2021 Net Sales at Rs 1,850.37 crore, up 15.09% Y-o-Y
✔️ Glenmark Pharma launches anti-epileptic drug in US
✔️ Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 29-05-2021 To 31-05-2021
-: Stock News :- GLENMARK 29-05-2021 To 31-05-2021

✔️ Glenmark Pharma Q4 results: PAT jumps 6% to Rs 234 crore
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 28-05-2021 To 31-05-2021
-: Stock News :- GLENMARK 28-05-2021 To 31-05-2021

✔️ Market Ahead Podcast, May 28: Top factors that could guide markets today
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 27-05-2021 To 31-05-2021
-: Stock News :- GLENMARK 27-05-2021 To 31-05-2021

✔️ Glenmark arm, Emcure, 3 other pharma companies line up Rs 7,000 crore IPOs
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 24-05-2021 To 31-05-2021
-: Stock News :- GLENMARK 24-05-2021 To 31-05-2021

✔️ Glenmark Pharma gets USFDA nod for Icatibant Injection
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 10-05-2021 To 31-05-2021
-: Stock News :- GLENMARK 10-05-2021 To 31-05-2021

✔️ Hot Stocks | Here's why LIC Housing Finance and Glenmark Pharma are top buys
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 03-05-2021 To 31-05-2021
-: Stock News :- GLENMARK 03-05-2021 To 31-05-2021

✔️ Glenmark Pharma launches nasal spray Ryaltris in India
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 26-04-2021 To 31-05-2021
-: Stock News :- GLENMARK 26-04-2021 To 31-05-2021

✔️ Glenmark Pharma to launch its nasal spray Ryaltris in European Union
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 19-04-2021 To 31-05-2021
-: Stock News :- GLENMARK 19-04-2021 To 31-05-2021

✔️ Glenmark Arm Files Papers For Rs 1,160 Crore Glenmark Life Sciences' IPO
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 18-04-2021 To 31-05-2021
-: Stock News :- GLENMARK 18-04-2021 To 31-05-2021

✔️ Glenmark Life Sciences Files IPO Papers With Sebi
✔️ Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 17-04-2021 To 31-05-2021
-: Stock News :- GLENMARK 17-04-2021 To 31-05-2021

✔️ Glenmark Pharma arm files paperwork for IPO with market regulator
✔️ Glenmark Life Sciences files papers for IPO with Sebi
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 15-04-2021 To 31-05-2021
-: Stock News :- GLENMARK 15-04-2021 To 31-05-2021

✔️ Domestic growth trajectory to remain strong for Glenmark in near term
✔️ Glenmark Life Sciences files papers for IPO with Sebi
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 09-04-2021 To 31-05-2021
-: Stock News :- GLENMARK 09-04-2021 To 31-05-2021

✔️ Here is a Bull Spread Strategy on Glenmark Pharma by HDFC Securities
✔️ Glenmark Life Sciences files papers for IPO with Sebi
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 05-04-2021 To 31-05-2021
-: Stock News :- GLENMARK 05-04-2021 To 31-05-2021

✔️ Improved cash flows, debt reduction crucial for Glenmark's prospects
✔️ Glenmark Life Sciences files papers for IPO with Sebi
✔️ Glenmark Pharma Q4 net profit up 6% at Rs 233.87 crore
✔️ Glenmark Q4 net profit up 6% at 233.87 cr
✔️ Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 cr
✔️ What should investors do with Glenmark Pharma post Q4 earnings: Buy, sell or hold?
✔️ Glenmark expects 10-12% sales growth in FY22, anticipates value unlock of its RD business

View Full Story
-: Stock News :- GLENMARK 24-03-2021 To 23-03-2021
-: Stock News :- GLENMARK 24-03-2021 To 23-03-2021

✔️ Glenmark gets USFDA nod for generic antipsychotic drug
✔️ Glenmark Pharmaceuticals gets USFDA nod for generic antipsychotic drug
✔️ Glenmark Pharma share price gains on USFDA nod for Chlorpromazine Hydrochloride tablets
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 22-03-2021 To 23-03-2021
-: Stock News :- GLENMARK 22-03-2021 To 23-03-2021

✔️ Glenmark joins hands with Bausch to commercialise nasal spray in Canada
✔️ Glenmark Pharmaceuticals gets USFDA nod for generic antipsychotic drug
✔️ Glenmark Pharma share price gains on USFDA nod for Chlorpromazine Hydrochloride tablets
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 05-03-2021 To 23-03-2021
-: Stock News :- GLENMARK 05-03-2021 To 23-03-2021

✔️ Glenmark Pharma signs Rohit Sharma as brand ambassador for Candid Powder
✔️ Glenmark Pharmaceuticals gets USFDA nod for generic antipsychotic drug
✔️ Glenmark Pharma share price gains on USFDA nod for Chlorpromazine Hydrochloride tablets
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 22-02-2021 To 23-03-2021
-: Stock News :- GLENMARK 22-02-2021 To 23-03-2021

✔️ Glenmark arm gets Russian Health Ministry nod for nasal spray Ryaltris
✔️ Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris
✔️ Glenmark Pharma share price gains on USFDA nod for Chlorpromazine Hydrochloride tablets
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 17-02-2021 To 23-03-2021
-: Stock News :- GLENMARK 17-02-2021 To 23-03-2021

✔️ Buy Glenmark Pharmaceuticals; target of Rs 635: ICICI Direct
✔️ Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris
✔️ Glenmark Pharma share price gains on USFDA nod for Chlorpromazine Hydrochloride tablets
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 16-02-2021 To 23-03-2021
-: Stock News :- GLENMARK 16-02-2021 To 23-03-2021

✔️ Asset monetisation, sales uptick in US key triggers for Glenmark Pharma
✔️ Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris
✔️ Glenmark Pharma share price gains on USFDA nod for Chlorpromazine Hydrochloride tablets
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 13-02-2021 To 23-03-2021
-: Stock News :- GLENMARK 13-02-2021 To 23-03-2021

✔️ Glenmark Q3 net profit rises 30% at Rs 248.17 crore
✔️ Glenmark Q3 results: Net profit rises by 30% to Rs 248 crore
✔️ Glenmark Pharmaceuticals net profit up 30% at Rs 248.17 cr in Dec qtr
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 11-02-2021 To 23-03-2021
-: Stock News :- GLENMARK 11-02-2021 To 23-03-2021

✔️ Glenmark Pharma gets USFDA nod for acne treatment drug
✔️ Glenmark gets USFDA nod for acne treatment drug
✔️ Glenmark Pharmaceuticals net profit up 30% at Rs 248.17 cr in Dec qtr
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 03-02-2021 To 23-03-2021
-: Stock News :- GLENMARK 03-02-2021 To 23-03-2021

✔️ Glenmark Pharma gets USFDA nod for seizure treatment drug
✔️ Glenmark Pharma share price up 2% on final approval from USFDA for Topiramate Extended-Release Capsules
✔️ Glenmark Pharmaceuticals net profit up 30% at Rs 248.17 cr in Dec qtr
✔️ Glenmark Pharmaceuticals gets $40-million Covid loan from IFC
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 28-01-2021 To 23-03-2021
-: Stock News :- GLENMARK 28-01-2021 To 23-03-2021

✔️ Glenmark Pharma share price rises on US FDA final approval
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 18-01-2021 To 23-03-2021
-: Stock News :- GLENMARK 18-01-2021 To 23-03-2021

✔️ Glenmark Pharmaceuticals Q3 PAT seen up 27.4% YoY to Rs. 190.8 cr: Prabhudas Lilladher
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 31-12-2020 To 23-03-2021
-: Stock News :- GLENMARK 31-12-2020 To 23-03-2021

✔️ Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 29-12-2020 To 23-03-2021
-: Stock News :- GLENMARK 29-12-2020 To 23-03-2021

✔️ Glenmark launches fixed dose combination drug for diabetes
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 23-12-2020 To 23-03-2021
-: Stock News :- GLENMARK 23-12-2020 To 23-03-2021

✔️ Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe
✔️ Glenmark Pharma shares rise on licensing agreement with Menarini
✔️ Glenmark Pharma gets USFDA nod for nervous system stimulant drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 21-12-2020 To 23-03-2021
-: Stock News :- GLENMARK 21-12-2020 To 23-03-2021

✔️ Glenmark Pharma share price rises nearly 3% on tentative approval from USFDA
✔️ Glenmark Pharma gets tentative nod from USFDA for anticoagulant drug
✔️ Glenmark Pharma gets tentative nod from USFDA for blood thinning drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 01-12-2020 To 23-03-2021
-: Stock News :- GLENMARK 01-12-2020 To 23-03-2021

✔️ Glenmark Pharma share price gains on tentative USFDA nod for kidney cancer drug
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 25-11-2020 To 23-03-2021
-: Stock News :- GLENMARK 25-11-2020 To 23-03-2021

✔️ As refinancing risks ease, S&P; affirms Glenmark Pharma's 'BB-' rating
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 23-11-2020 To 23-03-2021
-: Stock News :- GLENMARK 23-11-2020 To 23-03-2021

✔️ Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark Pharmaceuticals
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 12-11-2020 To 23-03-2021
-: Stock News :- GLENMARK 12-11-2020 To 23-03-2021

✔️ Buy Glenmark Pharmaceuticals: target of Rs 635: ICICI Direct
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 11-11-2020 To 23-03-2021
-: Stock News :- GLENMARK 11-11-2020 To 23-03-2021

✔️ Glenmark Pharmaceuticals gets US FDA approval for Tacrolimus Capsules USP
✔️ Glenmark Pharma Gets Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
✔️ Glenmark Pharma gets USFDA nod for Tacrolimus capsules
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 09-11-2020 To 23-03-2021
-: Stock News :- GLENMARK 09-11-2020 To 23-03-2021

✔️ Glenmark to end FY21 with better margins led by low expenses, India sales growth and US business rebound
✔️ Glenmark Pharma Gets Nod For Tacrolimus Capsules; Stock Gains Nearly 2%
✔️ Glenmark Pharma gets USFDA nod for Tacrolimus capsules
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 06-11-2020 To 23-03-2021
-: Stock News :- GLENMARK 06-11-2020 To 23-03-2021

✔️ Glenmark Q2 net profit at Rs 234 crore
✔️ Top buy and sell ideas by Ashwani Gujral, Mitessh Thakkar for short term
✔️ Glenmark Pharma gets USFDA nod for Tacrolimus capsules
✔️ Glenmark Pharma gets USFDA approval for nervous system stimulant drug
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 14-10-2020 To 23-03-2021
-: Stock News :- GLENMARK 14-10-2020 To 23-03-2021

✔️ Glenmark launches medicine for pulmonary fibrosis at Rs 4,500 per month
✔️ Glenmark Pharma launches pulmonary fibrosis treatment drug in India
✔️ Covid medicines help Cipla, Glenmark post strong sales growth in a subdued pharma market
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 11-10-2020 To 23-03-2021
-: Stock News :- GLENMARK 11-10-2020 To 23-03-2021

✔️ Smaller pharma firms post faster domestic sales growth in September
✔️ Glenmark Pharma launches pulmonary fibrosis treatment drug in India
✔️ Covid medicines help Cipla, Glenmark post strong sales growth in a subdued pharma market
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 09-10-2020 To 23-03-2021
-: Stock News :- GLENMARK 09-10-2020 To 23-03-2021

✔️ Glenmark's antiviral combination for moderate Covid-19 shows no benefit
✔️ No significant benefit of Umifenovir in Covid-19 treatment: Glenmark
✔️ Covid medicines help Cipla, Glenmark post strong sales growth in a subdued pharma market
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 07-10-2020 To 23-03-2021
-: Stock News :- GLENMARK 07-10-2020 To 23-03-2021

✔️ Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis
✔️ Glenmark Pharma gets USFDA nod to market drug for multiple sclerosis relapse
✔️ Glenmark Pharma share price rises on final USFDA approval for a generic
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 21-09-2020 To 23-03-2021
-: Stock News :- GLENMARK 21-09-2020 To 23-03-2021

✔️ Higher sales in domestic market, lower costs bode well for Glenmark
✔️ Glenmark Pharma gets USFDA nod to market drug for multiple sclerosis relapse
✔️ Glenmark Pharma share price rises on final USFDA approval for a generic
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 14-09-2020 To 23-03-2021
-: Stock News :- GLENMARK 14-09-2020 To 23-03-2021

✔️ Glenmark: Domestic sales performance, lower costs bode well for the stock
✔️ Glenmark Pharma gets USFDA nod to market drug for multiple sclerosis relapse
✔️ Glenmark Pharma share price rises on final USFDA approval for a generic
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 11-09-2020 To 23-03-2021
-: Stock News :- GLENMARK 11-09-2020 To 23-03-2021

✔️ Quant Pick - Glenmark Pharma: ICICI Direct
✔️ Glenmark Pharma gets USFDA nod to market drug for multiple sclerosis relapse
✔️ Glenmark Pharma share price rises on final USFDA approval for a generic
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 21-08-2020 To 23-03-2021
-: Stock News :- GLENMARK 21-08-2020 To 23-03-2021

✔️ Buy Glenmark Pharma; target of Rs 576 KRChoksey
✔️ Glenmark Pharma gets USFDA nod to market drug for multiple sclerosis relapse
✔️ Glenmark Pharma share price rises on final USFDA approval for a generic
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 20-08-2020 To 23-03-2021
-: Stock News :- GLENMARK 20-08-2020 To 23-03-2021

✔️ To raise funds, Glenmark to divest stake in drug development arm Ichnos
✔️ Buy Glenmark Pharma; target of Rs 575: Emkay Global Financial
✔️ Glenmark Pharma share price rises on final USFDA approval for a generic
✔️ Glenmark Faith' trial for Covid-19: No major clinical benefit from antiviral combination
✔️ Glenmark becomes first domestic drug firm to get COVID credit line from IFC
✔️ Glenmark gets $40 million COVID credit line from International Finance Corporation
✔️ Glenmark gets USFDA nod for generic high blood pressure drug
✔️ Glenmark gets USFDA nod for generic high blood pressure drug

View Full Story
-: Stock News :- GLENMARK 18-08-2020 To 17-08-2020
-: Stock News :- GLENMARK 18-08-2020 To 17-08-2020

✔️ Slow US growth and high debt continue to weigh on Glenmark Pharma
✔️ Glenmark Pharma shares trade lower after CLSA retains 'sell'
✔️ Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
✔️ Glenmark Pharmaceuticals gains 7% on strong June quarter performance
✔️ Glenmark Pharma jumps 7% on over two-fold rise in Q1 profit
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 14-08-2020 To 17-08-2020
-: Stock News :- GLENMARK 14-08-2020 To 17-08-2020

✔️ Glenmark Q1 net jumps over two-fold, revenue up marginally at Rs 2,344.8 cr
✔️ Glenmark Q1 net jumps over two-fold to ?254 cr on Favipiravir launch
✔️ Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
✔️ Glenmark Pharmaceuticals gains 7% on strong June quarter performance
✔️ Glenmark Pharma jumps 7% on over two-fold rise in Q1 profit
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 11-08-2020 To 17-08-2020
-: Stock News :- GLENMARK 11-08-2020 To 17-08-2020

✔️ Covid shows drugmakers needtocollaboratein R&D;'
✔️ Glenmark Q1 net jumps over two-fold to ?254 cr on Favipiravir launch
✔️ Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
✔️ Glenmark Pharmaceuticals gains 7% on strong June quarter performance
✔️ Glenmark Pharma jumps 7% on over two-fold rise in Q1 profit
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 06-08-2020 To 17-08-2020
-: Stock News :- GLENMARK 06-08-2020 To 17-08-2020

✔️ Glenmark to launch higher strength Favipiravir to reduce pill-burden to patients
✔️ Glenmark to launch 400 mg `FabiFlu' for Covid treatment
✔️ Glenmark to launch higher strength of FabiFlu
✔️ Coronavirus treatment: Glenmark to launch 400 mg tablets of Favipiravir drug, FabiFlu
✔️ Glenmark to launch higher strength of FabiFlu to manage Covid-19 dosage
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 04-08-2020 To 17-08-2020
-: Stock News :- GLENMARK 04-08-2020 To 17-08-2020

✔️ Sun Pharma launches cheapest favipiravir brand in India, at Rs 35 a pill
✔️ Glenmark to launch 400 mg `FabiFlu' for Covid treatment
✔️ Glenmark to launch higher strength of FabiFlu
✔️ Coronavirus treatment: Glenmark to launch 400 mg tablets of Favipiravir drug, FabiFlu
✔️ Glenmark to launch higher strength of FabiFlu to manage Covid-19 dosage
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 02-08-2020 To 17-08-2020
-: Stock News :- GLENMARK 02-08-2020 To 17-08-2020

✔️ Stock query: Glenmark on medium-term uptrend
✔️ Glenmark to launch 400 mg `FabiFlu' for Covid treatment
✔️ Glenmark to launch higher strength of FabiFlu
✔️ Coronavirus treatment: Glenmark to launch 400 mg tablets of Favipiravir drug, FabiFlu
✔️ Glenmark to launch higher strength of FabiFlu to manage Covid-19 dosage
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 31-07-2020 To 17-08-2020
-: Stock News :- GLENMARK 31-07-2020 To 17-08-2020

✔️ Stock calls by Nilesh Jain of Anand Rathi: Buy Glenmark Pharma, Tata Elxsi
✔️ DCGI rejects normal marketing approval request for Glenmark's FabiFlu
✔️ Glenmark Pharma surges 6% as S&P; Global sees stable cash flow in 2 years
✔️ Coronavirus treatment: Glenmark to launch 400 mg tablets of Favipiravir drug, FabiFlu
✔️ Glenmark to launch higher strength of FabiFlu to manage Covid-19 dosage
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 23-07-2020 To 17-08-2020
-: Stock News :- GLENMARK 23-07-2020 To 17-08-2020

✔️ Covid treatment: Brinton Pharma's Favipiravir tab set to trigger a price-war
✔️ Cheaper favipiravir brand gets nod, to enter market at Rs 59 a pill
✔️ Glenmark Pharma surges 6% as S&P; Global sees stable cash flow in 2 years
✔️ Coronavirus treatment: Glenmark to launch 400 mg tablets of Favipiravir drug, FabiFlu
✔️ Glenmark to launch higher strength of FabiFlu to manage Covid-19 dosage
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 22-07-2020 To 17-08-2020
-: Stock News :- GLENMARK 22-07-2020 To 17-08-2020

✔️ Glenmark says trial showed favipiravir use led to 40% faster cure from covid-19
✔️ Glenmark releases phase-3 trial data, says favipiravir helps cure faster
✔️ Glenmark says FabiFlu shows positive results in Phase 3; mild, moderate COVID-19 cases improved faster
✔️ Coronavirus treatment: Glenmark to launch 400 mg tablets of Favipiravir drug, FabiFlu
✔️ Glenmark to launch higher strength of FabiFlu to manage Covid-19 dosage
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 21-07-2020 To 17-08-2020
-: Stock News :- GLENMARK 21-07-2020 To 17-08-2020

✔️ Top headlines: Glenmark defends FabiFlu, Covid antibody in Delhi residents
✔️ FabiFlu 'cheapest' COVID-19 drug; Glenmark calls overpricing charge baseless
✔️ Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version
✔️ Coronavirus drug: Glenmark defends FabiFlu pricing after DGCI notice
✔️ Glenmark defends price of its covid-19 drug favipiravir version
✔️ Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 crore
✔️ Glenmark Pharma shares jump 7% on strong Q1 results
✔️ Glenmark Consolidated June 2020 Net Sales at Rs 2,344.79 crore, up 0.94% Y-o-Y
✔️ Glenmark Pharma shares gain after Q1 profit jumps two-fold to Rs 254 crore
✔️ Glenmark Pharma leaps 7% after posting two-fold jump in Q1 profit
✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

View Full Story
-: Stock News :- GLENMARK 21-07-2020 To 19-07-2020
-: Stock News :- GLENMARK 21-07-2020 To 19-07-2020

✔️ Glenmark defends pricing of Covid-19 drug FabiFlu, says it is economical
✔️ Favipiravir priced a notch lower than in other countries, says Glenmark
✔️ Glenmark-DCGI face-off over Covid drug, a sign of things to come
✔️ Glenmark shares fall 5.8% after DCGI notice on overpricing
✔️ Glenmark drops 5% as DCGI seeks clarity on Covid-19 drug
✔️ MARKET LIVE: Indices likely to open lower; HDFC Bank, Glenmark in focus
✔️ Glenmark under fire for over pricing, 'misguided' claims of Covid-19 drug
✔️ DCGI seeks clarification from Glenmark on Fabiflu pricing
✔️ Glenmark gets DCGI notice over 'false claims', price of Covid drug FabiFlu
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 14-07-2020 To 19-07-2020
-: Stock News :- GLENMARK 14-07-2020 To 19-07-2020

✔️ Coronavirus drug: Biophore India gets DCGI nod to manufacture Favipiravir
✔️ Glenmark slashes covid-19 drug FabiFlu price by 27% to 75 a pill
✔️ Glenmark cuts price of COVID-19 drug by 27% to Rs 75 per tablet
✔️ Glenmark cuts price of Covid drug Favipiravirby 27%, begins post-marketing surveillance
✔️ Glenmark cuts price of Covid drug FabiFlu by 27% within a month of launch
✔️ Glenmark reduces price of COVID-19 drug FabiFlu to Rs 75 from Rs 103 per tablet
✔️ COVID-19 medicine price reduced to 75 per tablet by Glenmark Pharma
✔️ Coronavirus pandemic | Glenmark Pharma cuts price of favipiravirby27% to Rs 75/tablet
✔️ Glenmark cuts price on Covid drug Favipiravir
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 05-07-2020 To 19-07-2020
-: Stock News :- GLENMARK 05-07-2020 To 19-07-2020

✔️ Is the Covid-19 drug good news for Glenmark Pharmaceuticals?
✔️ Glenmark slashes covid-19 drug FabiFlu price by 27% to 75 a pill
✔️ Glenmark cuts price of COVID-19 drug by 27% to Rs 75 per tablet
✔️ Glenmark cuts price of Covid drug Favipiravirby 27%, begins post-marketing surveillance
✔️ Glenmark cuts price of Covid drug FabiFlu by 27% within a month of launch
✔️ Glenmark reduces price of COVID-19 drug FabiFlu to Rs 75 from Rs 103 per tablet
✔️ COVID-19 medicine price reduced to 75 per tablet by Glenmark Pharma
✔️ Coronavirus pandemic | Glenmark Pharma cuts price of favipiravirby27% to Rs 75/tablet
✔️ Glenmark cuts price on Covid drug Favipiravir
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 02-07-2020 To 19-07-2020
-: Stock News :- GLENMARK 02-07-2020 To 19-07-2020

✔️ Sell Glenmark Pharmaceuticals; target of Rs 365: Prabhudas Lilladher
✔️ Coronavirus in Mumbai: BMC to buy 27 lakh Favipiravir tablets for Rs 80 per tablet from Glenmark
✔️ Glenmark cuts price of COVID-19 drug by 27% to Rs 75 per tablet
✔️ Glenmark cuts price of Covid drug Favipiravirby 27%, begins post-marketing surveillance
✔️ Glenmark cuts price of Covid drug FabiFlu by 27% within a month of launch
✔️ Glenmark reduces price of COVID-19 drug FabiFlu to Rs 75 from Rs 103 per tablet
✔️ COVID-19 medicine price reduced to 75 per tablet by Glenmark Pharma
✔️ Coronavirus pandemic | Glenmark Pharma cuts price of favipiravirby27% to Rs 75/tablet
✔️ Glenmark cuts price on Covid drug Favipiravir
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 01-07-2020 To 19-07-2020
-: Stock News :- GLENMARK 01-07-2020 To 19-07-2020

✔️ US charges Glenmark Pharma with conspiracy in price fixing
✔️ Glenmark Pharma share falls 6% on price-fixing allegations in US, here's what brokerages say
✔️ Glenmark to defend position in US price-fixing case
✔️ Neutral Glenmark Pharma; target of Rs 430: Motilal Oswal
✔️ US charges generic drug firm Glenmark with conspiracy in price-fixing
✔️ Buy Glenmark Pharma; target of Rs 526: Emkay Global Financial
✔️ US charges generic drug firm Glenmark with price-fixing
✔️ Glenmark Pharma falls 5% on CLSA downgrade after Q4 earnings
✔️ Cipla and Glenmark top picks in the pharma space: Choksey
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 29-06-2020 To 19-07-2020
-: Stock News :- GLENMARK 29-06-2020 To 19-07-2020

✔️ Glenmark's Q4 shows decent progress, but managing cash flows critical
✔️ Glenmark Pharma share falls 6% on price-fixing allegations in US, here's what brokerages say
✔️ Glenmark to defend position in US price-fixing case
✔️ Neutral Glenmark Pharma; target of Rs 430: Motilal Oswal
✔️ US charges generic drug firm Glenmark with conspiracy in price-fixing
✔️ Buy Glenmark Pharma; target of Rs 526: Emkay Global Financial
✔️ US charges generic drug firm Glenmark with price-fixing
✔️ Glenmark Pharma falls 5% on CLSA downgrade after Q4 earnings
✔️ Cipla and Glenmark top picks in the pharma space: Choksey
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 26-06-2020 To 19-07-2020
-: Stock News :- GLENMARK 26-06-2020 To 19-07-2020

✔️ Glenmark Pharma Q4 net profit jumps 36% to Rs 220 crore
✔️ Glenmark Pharma posts Rs 220 crore Q4 net profit
✔️ Glenmark to defend position in US price-fixing case
✔️ Neutral Glenmark Pharma; target of Rs 430: Motilal Oswal
✔️ US charges generic drug firm Glenmark with conspiracy in price-fixing
✔️ Buy Glenmark Pharma; target of Rs 526: Emkay Global Financial
✔️ US charges generic drug firm Glenmark with price-fixing
✔️ Glenmark Pharma falls 5% on CLSA downgrade after Q4 earnings
✔️ Cipla and Glenmark top picks in the pharma space: Choksey
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 25-06-2020 To 19-07-2020
-: Stock News :- GLENMARK 25-06-2020 To 19-07-2020

✔️ Buy Glenmark Pharma; target of Rs 488: ICICI Securities
✔️ Glenmark Pharma stock corrects over 7% on profit-booking
✔️ Glenmark Pharma corrects 7% on profit booking
✔️ Glenmark Pharmaceuticals declines 13% in two days on profit booking
✔️ Sell Glenmark Pharmaceuticals; target of Rs 257: Prabhudas Lilladher
✔️ Shares of Glenmark Pharma slump 7% on profit booking
✔️ Is euphoria around Glenmark stock misplaced?
✔️ Can't call Remdesiver, Favipiravir game changers in Covid-19 fight: Experts
✔️ Glenmark soars on Covid-19 drug launch
✔️ DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu
✔️ DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu

View Full Story
-: Stock News :- GLENMARK 15-08-2022 To 15-08-2022
-: Stock News :- GLENMARK 15-08-2022 To 15-08-2022

✔️ Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal

View Full Story
-: Stock News :- GLENMARK 10-08-2022 To 10-08-2022
-: Stock News :- GLENMARK 10-08-2022 To 10-08-2022

✔️ Glenmark Pharmaceuticals' Q1 net profit drops 31% to Rs 211.1 crore
✔️ Glenmark Pharma revenue falls 6.3% at Rs27,773 million for Q1

View Full Story
-: Stock News :- GLENMARK 29-07-2022 To 29-07-2022
-: Stock News :- GLENMARK 29-07-2022 To 29-07-2022

✔️ Glenmark Pharma arm gets final USFDA nod for birth control capsules
✔️ Glenmark Pharma arm gets final USFDA nod for birth control capsules

View Full Story
-: Stock News :- GLENMARK 28-06-2022 To 29-07-2022
-: Stock News :- GLENMARK 28-06-2022 To 29-07-2022

✔️ Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US
✔️ Glenmark Pharma arm gets final USFDA nod for birth control capsules

View Full Story
-: Stock News :- GLENMARK 16-06-2022 To 29-07-2022
-: Stock News :- GLENMARK 16-06-2022 To 29-07-2022

✔️ Glenmark Pharma launches asthma drug Indamet
✔️ Glenmark Pharma arm gets final USFDA nod for birth control capsules

View Full Story
-: Stock News :- GLENMARK 13-06-2022 To 29-07-2022
-: Stock News :- GLENMARK 13-06-2022 To 29-07-2022

✔️ Glenmark Pharma shares hit 52-week low on reports of USFDA inspection at Baddi plant
✔️ Glenmark Pharma arm gets final USFDA nod for birth control capsules

View Full Story

No More Records...